Eun-Hee Kim

Eun-Hee Kim

Auto-generated profile, based on publicly available information

Eun-Hee Kim

Department of Pediatrics, CHA Gangnam Medical Center, CHA University, Seoul, Korea

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2022 in Clinical and Experimental Pediatrics
Verified
Journal Article
Open access
PDF file
EKEun-Hee Kim
Eun-Hee Kim
JSJEONGMIN SHIN
JEONGMIN SHIN
BLByoung Kook Lee
Byoung Kook Lee
Neonatal seizures are the most common neurological symptoms caused by various etiologies in the neonatal period, but their diagnosis and treatment are challenging because their pathophysiology and electroclinical manifestations differ from those of patients in older age groups. Many seizures present as electrographic-only events without clinical signs or as obscure clinical manifestations that are difficult to distinguish from other neonatal behaviors. Accordingly, a new definition and classification of neonatal seizures was recently proposed by the International League Against Epilepsy Task Force on neonatal seizures, highlighting the role of electroencephalography in diagnosing and treating neonatal seizures. Neonatal seizures are defined as electrographic events with sudden, paroxysmal, and abnormal alteration of activity and divided into electroclinical seizures and electrographic-only seizures according to their clinical signs, thus excluding clinical events without an electrographic correlation. Seizure types are described by their predominant clinical features and divided into motor (automatisms, clonic, epileptic spasms, myoclonic, tonic, and sequential), nonmotor (autonomic and behavioral arrest), and unclassified. Although many neonatal seizures are acute reactive events caused by hypoxic-ischemic encephalopathy or vascular insults, structural, genetic, or metabolic etiologies of neonatal-onset epilepsy should also be thoroughly evaluated to determine their appropriate management.

1 January 2020 in Journal of Clinical Neurology
Verified
Journal Article
Open access
PDF file
EKEun-Hee Kim
Eun-Hee Kim
WSWoo-Hyun Shim
Woo-Hyun Shim
JLJin-Seong Lee
Jin-Seong Lee
HYHee-Mang Yoon
Hee-Mang Yoon
TKTae-Sung Ko
Tae-Sung Ko
MYMi-Sun Yum
Mi-Sun Yum
Kim EH, et al. J Clin Neurol. 2020 Oct;16(4):573-580. https://doi.org/10.3988/jcn.2020.16.4.573

11 November 2020 in Frontiers in Pediatrics
Verified
Journal Article
Open access
PDF file
EKEun-Hee Kim
Eun-Hee Kim
KKKi Eun Kim
Ki Eun Kim
JJJihyun Jeon
Jihyun Jeon
YSYoun Ho Sheen
Youn Ho Sheen
HLHyun-Seung Lee
Hyun-Seung Lee
KCKyoung Min Choi
Kyoung Min Choi
The prevalence of deformational plagiocephaly (DP) has increased since the recommendation of positioning infants to their back during sleeping and is affected by various biological and environmental factors. This study aimed to investigate associations between DP and perinatal or infant characteristics, including obesity. This case–control study included 135 infants (81 males) aged 2–12 months who were diagnosed with DP using calculated cranial vault asymmetric index and cranial index and 135 age- and sex-matched controls. Motor development was evaluated using the Alberta Infant Motor Scale, and obesity was defined by body mass index. Univariate and multivariate logistic regression models were used to assess potential risk factors for DP and its severity. One hundred thirty-five infants with DP were divided into the following three subgroups according to severity indicated by the cranial vault asymmetry index: mild to moderate group (n = 87, 64.4%), severe group (n = 48, 35.6%), and a combined plagiocephaly and brachycephaly group (n = 79, 58.5%). Independent risk factors significantly associated with development of DP were bottle-only feeding (adjusted odds ratio (aOR) = 4.65; 95% CI: 2.70–8.00), little tummy time when awake (aOR = 3.51, 95% CI: 1.71–7.21), delay of motor development (aOR = 2.85, 95% CI: 1.08–7.49), and obesity at diagnosis (aOR = 2.45, 95% CI: 1.02–5.90). Among these risk factors, delay of motor development (aOR = 4.91, 95% CI: 1.46–16.51) and obesity at diagnosis (aOR = 4.10, 95% CI: 1.42–11.90) were particularly related to severe DP. In conclusion, this study confirms that DP risk is positively associated with bottle-only feeding, infrequent tummy time, and delayed development of motor milestones. Notably, this study demonstrates infant obesity as a new risk factor for DP. Our findings suggest that obesity should be identified early and managed comprehensively in infants with DP.

1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
JHJu Sun Heo
Ju Sun Heo
JSJoo Young Song
Joo Young Song
ECEun Young Choi
Eun Young Choi
EKEun-Hee Kim
Eun-Hee Kim
JKJi Hee Kim
Ji Hee Kim
JJJi-Hyun Jeon
Ji-Hyun Jeon
Heo JS, et al. J Korean Med Sci. 2017 Jan;32(1):1-3. https://doi.org/10.3346/jkms.2017.32.1.1

1 January 2017 in Journal of Korean Medical Science
Verified
Journal Article
Open access
PDF file
YLYun Jeong Lee
Yun Jeong Lee
MYMi-Sun Yum
Mi-Sun Yum
EKEun-Hee Kim
Eun-Hee Kim
MKMin-Jee Kim
Min-Jee Kim
KKKyung Mo Kim
Kyung Mo Kim
TKTae-Sung Ko
Tae-Sung Ko
Lee YJ, et al. J Korean Med Sci. 2017 Mar;32(3):457-464. https://doi.org/10.3346/jkms.2017.32.3.457

13 October 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
YKYoo-Mi Kim
Yoo-Mi Kim
HLHan-Hyuk Lim
Han-Hyuk Lim
EKEunhee Kim
Eunhee Kim
GKGeena Kim
Geena Kim
MKMinji Kim
Minji Kim
YLYoung Seok Lee
Young Seok Lee
The most common causes of short stature (SS) in children are familial short stature (FSS) and idiopathic short stature (ISS). Recently, growth plate dysfunction has been recognized as the genetic cause of FSS or ISS. The aim of this study was to investigate monogenic growth failure in patients with ISS and FSS. Targeted exome sequencing was performed in patients categorized as ISS or FSS and the subsequent response to growth hormone (GH) therapy was analyzed. We found 17 genetic causes involving 12 genes (NPR2, IHH, BBS1, COL1A1, COL2A1, TRPS1, MASP1, SPRED1, PTPTN11, ADNP, NADSYN1, and CERT1) and 2 copy number variants. A genetic cause was found in 45.5% and 35.7% of patients with FSS and ISS, respectively. The genetic yield in patients with syndromic and non-syndromic SS was 90% and 23.1%, respectively. In the 11 genetically confirmed patients, a gain in height from −2.6 to −1.3 standard deviations after 2 years of GH treatment was found. The overall diagnostic yield in this study was 41.7%. We identified several genetic causes involving paracrine signaling, the extracellular matrix, and basic intracellular processes. Identification of the causative gene may provide prognostic evidence for the use of GH therapy in non-SGA children.